Announcement
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 10 Aug
Source: Bse
Bhagiradha Chemicals & Industries Limited (BHAGCHEM)
Small CapIndustrials stocks · Small cap · NSE
Bhagiradha Chemicals & Industries Limited operates in Agrochemicals, within the Industrials sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers.
Data qualityFresh enough for analysisQuote updated 19 Oct, 03:31 pm ISTDetails
Quote19 Oct, 03:31 pm IST
Base fundamentals06 Oct 2026 · screener
Latest result03 Aug, 07:32 pm IST
Score20 Oct, 04:30 am IST · v4.3-runtime-valuation
Tags02 May 2026
Coverage13/14 · 93%
Valuation2026-07-20 · Rf 6.8% · Industrials P/E 26.2 (n=537)
Technical timing lens
Trend score and candlestick chart
40NeutralSMA20 -13.0% / mo · RSI oversold · MACD −
Stock trend: 33
Sector RS: 50
Sector 3M: -6.3% vs Nifty 500 -5.6%
Industrials FPI tailwindNot confirmed
Latest mapped FPI equity flow was not positive. View sector evidence
Technical chart
BHAGCHEMD candles · FIT view-20.3%Latest close ₹206.56 on 2026-10-19
Bar
-3.0%
RSI
25
MACD hist
-1.26
52W pos
25%
2026-10-19O ₹212.85H ₹212.85L ₹206.00C ₹206.56Vol 29,646 sh
Up bar
Down bar
EMA 20
EMA 50
Volume + 20D avg
Result date
RSI(14)
MACD / signal
Market context
Relative performance and chart statistics
Adjusted completed-session prices, rebased to 100
BHAGCHEMNifty India ManufacturingNifty 500
- BHAGCHEM
- -25.0%
- Nifty 500
- -5.6%
- Nifty India Manufacturing
- -5.8%
- Vs Nifty 500
- -19.4 pp
Chart stats
19 Oct 2026- From 52W high
- -34.8%
- 52W range position
- 25%
- ATR (14)
- 4.2%
- Volume vs 20D
- 0.19x
- Avg traded value
- ₹3.5 Cr
- 20D price channel
- ₹206 - ₹251.9
₹316.9
₹170.6 - ₹316.9
₹8.6
Latest completed session
20-session average
35.7% annualized volatility
Research snapshot
What the evidence says now
Weak fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend argues for patience, and recent execution is consistent.
Suggested next step
Research, do not rush
The evidence is not strongly aligned. Compare peers and wait for a cleaner setup.
U-Score
Legacy · OVERVALUED16
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
Latest result
Excellent100
Revenue +57.3% · PAT +225.0% YoY
Technical
Neutral40
Price trend and sector-relative-strength timing.
Valuation
Legacy model-1677.9%
Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.
Trust
Limited evidence60
Financial-only signal; management claim evidence is not sufficient yet.
Financials
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Financials
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Latest result
Quarter ended 30 Jun 2026
Excellent · 100/100Rev +57% YoY · PAT +225% YoY · margin expansion · +23% QoQ · operating leverage
Filed 03 Aug 2026
Open results browser →| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹195 Cr | +57.3% | +23.4% |
| EBITDA | ₹31 Cr | +244.4% | +63.2% |
| Operating margin | 16.0% | +900 bps | +400 bps |
| PAT | ₹13 Cr | +225.0% | +225.0% |
| PAT margin | 6.7% | +344 bps | +414 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Fundamentals
Valuation
- P/E
- 108.00
- P/B
- 4.26
- EV/EBITDA
- 30.83
- Market Cap
- 2971.00Cr
Profitability
- ROE
- 2.63%
- ROCE
- 4.53%
- ROA
- 2.50%
- Dividend Y
- 0.07%
Growth (CAGR)
- Revenue 5Y
- 11.00%
- EPS 5Y
- -4.00%
- Revenue 3Y
- 2.00%
- EPS 3Y
- -26.00%
Balance Sheet
- Debt/Equity
- 0.34
- Interest Coverage
- 3.76×
- Altman Z
- 6.08
- Book Value
- 53.80
Cash Flow
- FCF Yield
- —
- FCF Positive Y
- 1/5
- OCF
- 12.00 Cr
- EPS TTM
- 2.12
Shareholding
- Promoter Hold
- 19.60%
- Promoter Pledge
- 0.00%
- Momentum 52W
- 40%
Financial History
Updated 20/10/2026
Revenue
₹ CrLatest: 195+23.4% vs prev
Net Profit
₹ CrLatest: 13.0+225.0% vs prev
ROE is shown only in the Annual view — quarterly equity data isn't published.
Technicals
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Technicals
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Daily technical trend read
Bearish setupTrend is weak — long-term trend down. RSI 25.
- Price below SMA200 (long-term downtrend) — short-term bounces likely countertrend.
- SMA20 falling (~14.9% over last month) — short-term momentum negative.
- RSI(14) at 25 — oversold zone; bounce conditions.
- MACD below signal, histogram expanding negatively — bearish momentum building.
- 35% off 52W high · 21% above 52W low.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
Nifty 500 leadership
Relative Strength & Trend Stage
29
RS percentile
Stage 1 Base / Transition
1M return
-16.3%
3M return
-25.0%
6M return
-22.5%
1Y return
-18.2%
RS 1D
-5
RS 20D
-33
Sector rank
#2
Industry rank
#54
Stage evidence
- Price is 18.5% below the 30-week proxy without full trend alignment.
- The 30-week proxy changed +1.8% over 20 sessions.
- The moving-average structure does not confirm Stage 2 or Stage 4.
50-DMA
price below
200-DMA
price below
Sector
leading
Industry
weakening
Relative-strength line vs Nifty 500 (base 100)
262 observations
19 Oct 2026Value 85.18-2.05%
RS vs Nifty 50085
Valuation & peers
U-Score 16 · legacy U-Score band OVERVALUED · valuation evidence and comparable companies
Valuation & peers
U-Score 16 · legacy U-Score band OVERVALUED · valuation evidence and comparable companies
OVERVALUED
Fundamental score breakdown
U band · OVERVALUEDValuation0/30
Growth5/25
Quality0/20
Balance Sheet5/15
Cash Flow1/10
Piotroski
7/9 (+5)
Penalties
0
Raw sum
16
Why this score?
Top U-Score contributors and drags from the latest stored fundamentals.
16/100 · legacy band OVERVALUED
Positive drivers
- Piotroski is strong at 7/9.
- Balance sheet contributes 5/15 to the score.
- Growth contributes 5/25 to the score.
Main drags
- Fair-value margin of safety is negative at -1677.9%.
- Valuation is weaker at 0/30; verify the latest quarterly trend.
- Quality is weaker at 0/20; verify the latest quarterly trend.
Sector valuation model
Cyclical valuation: normalized earnings, not just trailing PE
Cyclical companies can look cheapest near peak profits, so IndiaPulse flags value-trap risk separately.
Primary lens
Mid-cycle PE/EV/EBITDA using multi-year average margins or earnings.
Secondary checks
Current margin versus 5-year average, balance sheet strength, commodity cycle.
Main risk check
A low trailing PE may mean peak-cycle earnings, not true cheapness.
PE
108.0
PB
4.3
EV/EBITDA
30.8
ROE
2.6%
ROCE
4.5%
FCF Yield
—
Debt/Equity
0.3
MoS
-1677.9%
Cyclical/value-trap warning
This sector can look cheap when profits are temporarily high. Check mid-cycle margins/earnings before relying on trailing PE.
Score movement
Stored run vs live recompute
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
Stored run: 20 Oct 2026
v4.3-runtime-valuation
Final score
16
Previous: 16
Legacy U-Score band
OVERVALUED
Previous: OVERVALUED
Margin of safety
-1677.9%
Previous: -1677.9%
Score history
12 stored score snapshots. Latest stored move: +0 points.
20 Oct 2026
v4.3-runtime-valuation
16
16
16
16
16
16
16
16
16
16
16
16
Factor attribution
No pillar movement versus the latest stored run. Historical score trend will appear after snapshot storage is enabled.
Modelled fair value
Graham Number
₹50.66
-307.8% MoS
Growth-justified P/E
5.5
Growth-justified Value
₹11.62
-1677.9% MoS
PEG
—
Comparable companies
Peers
Business-comparable peers in Industrials — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.
Ticker
Name
Why peer
Score
PE
ROE
MoS
Verdict
ASTEC
Small
Astec LifeSciences Limited
Agrochemicals
match 167
8
—
-25.2%
—
OVERVALUED
GSPCROP
Small
GSP Crop Science Limited
Agrochemicals
match 167
46
20.3
16.5%
+1%
FAIR VALUE
IPL
Small
India Pesticides Limited
Agrochemicals
match 164
46
13.8
12.5%
-110%
FAIR VALUE
HERANBA
Small
Heranba Industries Limited
Agrochemicals
match 164
16
—
-9.7%
—
OVERVALUED
DHANUKA
Small
Dhanuka Agritech Limited
Agrochemicals
match 163
76
13.9
22.0%
+67%
DEEP VALUE
Business, management & trust
Growth engines, risks, management commitments and evidence-backed delivery
Business, management & trust
Growth engines, risks, management commitments and evidence-backed delivery
Business and thesis
Issuer presentation review pending
Bhagiradha Chemicals & Industries Limited operates in Agrochemicals, within the Industrials sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers. The structured result feed currently covers the quarter ended 30 Jun 2026. Investor presentations and earnings-call PDFs will be added as issuer-backed evidence before management claims appear here.
Trust Score
60Limited evidence · low confidenceTrust Lite
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Limited evidence: Claim history is still being built. It ranks around the 28th percentile of the scored universe and 24th percentile within Industrials. Main check: financial discipline is weak at 40/100.
This is a financial-behaviour screen, not a claim-tested management reliability verdict.
Computed 05 Sept 2026
management-trust-v1
24 docs text-extracted · 0 concalls text-extracted
Score band
Limited evidence
Financial behaviour is scored, but management claims do not yet have enough outcome checks.
Relative rank
28th percentile
overall median 67 · Industrials: 24th pctile, median 68 · Small: 32nd pctile, median 66
Evidence depth
Financial-only
24 documents have extracted text, but claim history is not strong enough yet.
Claim delivery
Outcome history still building
0 claims extracted · No contradicted claim yet
How to read this Trust Score
Limited evidence · low confidenceWhat it measures
Reliability of management and financial delivery, using financial behaviour only.
Confidence
Treat this as an early read until more concalls and outcomes are matched.
Investor use
Acceptable, but check the weakest sub-score before increasing exposure.
Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Forensic breakdown
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Promoter
66
acceptable · holding, pledge, alignment
Cash flow
43
weak · profit to cash conversion
Balance sheet
81
strong · leverage and solvency
Discipline
40
weak · capital discipline
Results
80
strong · quarterly consistency
Trust positives
- ▸Promoter pledge is zero.
- ▸4/4 latest quarters had positive YoY revenue growth.
- ▸3/4 latest quarters had positive YoY PAT growth.
- ▸Latest 3 quarters had positive YoY PAT growth.
Trust risks
- ▸Promoter holding is only 19.6%.
- ▸Only 1 years of positive FCF.
- ▸ROCE is low at 4.5%.
- ▸ROE is low at 2.6%.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Continue researching Bhagiradha Chemicals & Industries Limited
Important announcements & filings
Latest exchange and company disclosures found within the past two years.
Open source ↗
Announcement
Announcement under Regulation 30 (LODR)-Newspaper Publication 9 Jul - Newspaper Publication regarding the 33rd AGM of the company, e-voting information etc.
Source: Bse
Announcement
Clarification On Significant Increase In The Volume Of Company'S Scrip 22 Jun - Company clarified recent volume spurt is market-driven, with no pending material announcement.
Source: Bse
Annual report
Annual Report 2026
Source: Bse
Annual report
Annual Report 2025
Source: Bse
Annual report
Business Responsibility and Sustainability Reporting (BRSR) 8 Jul - Bhagiradha Chemicals filed its BRSR for FY 2025-26 as part of the annual report.
Source: Bse
All information is for study purposes only. For investment decisions, consult your financial advisor. See Playbook for methodology.